Synopsys Inc. (NASDAQ:SNPS) shares moved up 0.76% in last trading session and ended the day at $46.22. SNPS Gross Margin is 76.90% and its has a return on assets of 4.50%. Synopsys Inc. (NASDAQ:SNPS) quarterly performance is -7.62%.
On 2 March, Synopsys Inc. (NASDAQ:SNPS) has acquired WinterLogic, the technology leader in fault simulation used in automotive, safety and security environments for the design and verification of advanced system on chips (SoCs). Fault simulation is a key technology for compliance testing of the ISO 26262 functional safety standard and its Automotive Safety Integrity Level (ASIL) classification.
Transocean Ltd. (NYSE:RIG) caters to the Basic Materials space. It has a net profit margin of -7.20% and weekly performance is 46.94%. On the last day of trading company shares ended up at $12.71. Transocean Ltd. (NYSE:RIG) distance from 50-day simple moving average (SMA50) is 25.74%.
On 3 March, Transocean Ltd. (NYSE:RIG) said that, Offshore drillers struggling with plunging demand will start getting more work before they get more money.
On 04 March, Leju Holdings Limited (NYSE:LEJU) shares moved up 0.25% and was closed at $4.01. Leju Holdings Limited (NYSE:LEJU) year to date (YTD) performance is -29.90%.
Leju Holdings Limited (NYSE:LEJU) announced that it will report its unaudited financial results for the fourth quarter and full year ended on December 31, 2015 before the U.S. markets open on March 15, 2016.
SandRidge Permian Trust (NYSE:PER) shares moved up 8.37% in last trading session and ended the day at $2.85. PER Gross Margin is 96.10% and its has a return on assets of 26.00%. SandRidge Permian Trust (NYSE:PER) quarterly performance is -18.35%.
SandRidge Permian Trust (NYSE:PER) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Wednesday, ARN reports.
Ardelyx, Inc. (NASDAQ:ARDX) caters to the Healthcare space. It has a net profit margin of -52.00% and weekly performance is -8.05%. On the last day of trading company shares ended up at $9.14. Ardelyx, Inc. (NASDAQ:ARDX) distance from 50-day simple moving average (SMA50) is -8.28%.
On 4 March, Ardelyx, Inc. (NASDAQ:ARDX) announced financial results for the fourth quarter and full-year ended December 31, 2015. Results from the second Phase 2b clinical trial evaluating tenapanor for the treatment of hyperphosphatemia in ESRD patients are expected in the second half of 2016
Leave a Reply